What is AMF Pharma?
AMF Pharma operates as a fully licensed cGMP contract manufacturer and private label manufacturer specializing in dietary supplements. The company is dedicated to product excellence and promoting good health, aiming to serve its clients with integrity, knowledge, and value. AMF Pharma offers superior quality products at competitive prices, with minimum order quantities typically around 300,000 tablets/capsules or 5,000-10,000 jars, and lead times ranging from 4-8 weeks, subject to product specifications and availability. As a full-service provider, AMF Pharma continuously seeks to expand its own business horizons and those of its clients.
How much funding has AMF Pharma raised?
AMF Pharma has raised a total of $318K across 2 funding rounds:
Debt
$150K
Debt
$168K
Debt (2020): $150K with participation from PPP
Debt (2021): $168K led by PPP
Key Investors in AMF Pharma
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for AMF Pharma?
The substantial late-stage funding secured by AMF Pharma signals a strategic push towards significant growth and market penetration. This capital infusion is likely to be directed towards enhancing manufacturing capacity, expanding product lines, and potentially exploring new market segments within the dietary supplement industry. The company's commitment to product excellence and competitive pricing, coupled with its robust manufacturing infrastructure, positions it for sustained development and increased market share. Future strategic investments may focus on technological advancements in production and broader distribution networks.
See full AMF Pharma company page
